insights_auto
Why is 4519 down 2,11%?
Dive Deeperchevron_right
4519:TYO
Chugai Pharmaceutical Co Ltd
6 040,00 JP¥
arrow_downward
-2,11%(-130,00) 1D
14-окт., 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
6 100 JP¥
High
6 106 JP¥
Low
6 036 JP¥
Mkt. cap
10,14 трлн
Avg. vol.
3,02 млн
Volume
2,36 млн
Dividend
2,28%
Quarterly dividend
34 JP¥
Ex-dividend date
2026-ж., 29-июн.
P/E ratio
21,09
52-wk high
10 700 JP¥
52-wk low
5 974 JP¥
EPS
286 JP¥
Shares outstanding
547,19 млн
No. of employees
5 миң
Open
6 100 JP¥
High
6 106 JP¥
Low
6 036 JP¥
Mkt. cap
10,14 трлн
Avg. vol.
3,02 млн
Volume
2,36 млн
Dividend
2,28%
Quarterly dividend
34 JP¥
Ex-dividend date
2026-ж., 29-июн.
P/E ratio
21,09
52-wk high
10 700 JP¥
52-wk low
5 974 JP¥
EPS
286 JP¥
Shares outstanding
547,19 млн
No. of employees
5 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
36 мүнөт мурун
Chugai reports vamikibart data for Chugai Pharmaceutical stock
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5,1 миң
Founded1925-ж., 10-мар.
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp